Globus Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Globus Medical (GMED).

Price Target Range — 13 Quarters

Analyst Consensus — 17 Analysts

11Buy

6Hold

Consensus RatingBuy# Analysts17Avg. Consensus PT$97Upside to Avg. PT+29.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 7, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Overweight	$103→$99
Jul 28, 2026	UBS	Matthew Taylor	Initiate	Neutral	$82
Jul 16, 2026	Truist Securities	Richard Newitter	PT Cut	Buy	$115→$100
Jul 13, 2026	RBC Capital	Shagun Singh	PT Cut	Outperform	$120→$115
Jul 9, 2026	BMO Capital	—	Initiate	Outperform	$94
Jul 8, 2026	Stifel	Tom Stephan	PT Cut	Hold	$95→$80
Jun 15, 2026	Piper Sandler	Matt O'Brien	PT Cut	Overweight	$115→$100
May 8, 2026	RBC Capital	Shagun Singh	PT Raise	Outperform	$115→$120
May 8, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Overweight	$104→$103
May 8, 2026	Needham	David Saxon	PT Raise	Buy	$114→$117
Feb 26, 2026	Wells Fargo	Vik Chopra	PT Raise	Overweight	$98→$104
Feb 25, 2026	Barclays	Matt Miksic	PT Raise	Overweight	$118→$123
Feb 25, 2026	Needham	David Saxon	PT Raise	Buy	$112→$114
Jan 30, 2026	Needham	David Saxon	Upgrade	Hold→Buy	$112
Jan 9, 2026	Canaccord Genuity	Caitlin Cronin	PT Raise	Buy	$105→$112
Jan 8, 2026	Piper Sandler	Matt O'Brien	PT Raise	Overweight	$90→$115
Dec 17, 2025	Canaccord Genuity	Caitlin Cronin	PT Raise	Buy	$90→$105
Dec 17, 2025	RBC Capital	Shagun Singh	PT Raise	Outperform	$92→$100
Dec 17, 2025	Freedom Capital Markets	Keith Hinton	Initiate	Hold	$87
Dec 2, 2025	Morgan Stanley	Drew Ranieri	PT Raise	Overweight	$70→$100

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Wells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $99

Wells Fargo analyst Larry Biegelsen maintains Globus Medical (NYSE:GMED) with a Overweight and lowers the price target from $103 to $99.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $100

Truist Securities analyst Richard Newitter maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $115 to $100.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $115

RBC Capital analyst Shagun Singh maintains Globus Medical (NYSE:GMED) with a Outperform and lowers the price target from $120 to $115.

Benzinga Newsdesk

PRO
BMO Capital Initiates Coverage On Globus Medical with Outperform Rating, Announces Price Target of $94

BMO Capital initiates coverage on Globus Medical (NYSE:GMED) with a Outperform rating and announces Price Target of $94.

Benzinga Newsdesk

PRO
Stifel Maintains Hold on Globus Medical, Lowers Price Target to $80

Stifel analyst Tom Stephan maintains Globus Medical (NYSE:GMED) with a Hold and lowers the price target from $95 to $80.

Benzinga Newsdesk

Paychex To Rally More Than 39%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on top names. See all rating changes on our analyst ratings page. Barclays, Wells Fargo, Piper Sandler, Leerink Partners, Truist Securities, and Citigroup updated their price targets and ratings for AVA, LEN, GMED, SABS, PDM, and PAYX. Evercore ISI Group and Truist Securities also raised their price targets and ratings for LEN and DDOG.

Avi Kapoor

Globus Medical Inc

Globus Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Wells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $99

PRO
Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $100

PRO
RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $115

PRO
BMO Capital Initiates Coverage On Globus Medical with Outperform Rating, Announces Price Target of $94

PRO
Stifel Maintains Hold on Globus Medical, Lowers Price Target to $80

Paychex To Rally More Than 39%? Here Are 10 Top Analyst Forecasts For Monday

People Also Watch

People Also Watch

Globus Medical Inc

Globus Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROWells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $99

PROTruist Securities Maintains Buy on Globus Medical, Lowers Price Target to $100

PRORBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $115

PROBMO Capital Initiates Coverage On Globus Medical with Outperform Rating, Announces Price Target of $94

PROStifel Maintains Hold on Globus Medical, Lowers Price Target to $80

Paychex To Rally More Than 39%? Here Are 10 Top Analyst Forecasts For Monday

People Also Watch

People Also Watch

PRO
Wells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $99

PRO
Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $100

PRO
RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $115

PRO
BMO Capital Initiates Coverage On Globus Medical with Outperform Rating, Announces Price Target of $94

PRO
Stifel Maintains Hold on Globus Medical, Lowers Price Target to $80